{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:46:42Z","timestamp":1787237202337,"version":"build-2736575974"},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>Urinary tract infection (UTI) of the urinary bladder is a common bacterial infection that predominantly affects women, with many experiencing recurrent episodes. Recurrent UTIs (rUTIs) are associated with significant physical, psychological, and social difficulties. Further, they are closely related to lower urinary tract dysfunction (LUTD). LUTD affects bladder function and structure, thereby contributing to urinary urgency, frequency, and incontinence, which, in turn, increases the risk of recurrent infections due to impaired urothelial defense mechanisms. The current study explored the pathophysiology of LUTD in women with rUTIs. Potential treatments for rUTIs include long-term prophylactic antibiotics, probiotics, D-mannose, vaccines, small molecule inhibitors, and stem cell therapy. Moreover, it evaluated the use of platelet-rich plasma (PRP) therapy as a treatment modality for LUTD. PRP has regenerative and anti-inflammatory properties. Hence, it can be a promising option for enhancing urothelial barrier integrity and reducing infection recurrence. Repeated intravesical PRP injections are effective in improving bladder symptoms and decreasing UTI recurrences by enhancing the proliferative ability of the urothelium in patients with rUTIs. Further, this review examined the potential predictors of successful PRP treatment outcomes such as cytokine and urothelial biomarker levels, which provided insights into patient selection and individualized treatment strategies. Identifying the predictive biomarkers of treatment responsiveness is essential for optimizing PRP therapy. Hence, to improve the clinical outcomes and quality of life of patients with rUTIs, future research should focus on refining the use of PRP, exploring combination therapies, and validating biomarkers.<\/jats:p>","DOI":"10.4103\/tcmj.tcmj_286_24","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T02:00:08Z","timestamp":1743991208000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Pathophysiology and potential treatment modalities in women with recurrent urinary tract infection"],"prefix":"10.4103","volume":"37","author":[{"given":"Wei-Ju","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"},{"name":"Department of Urology, School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fong","family":"Jhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"},{"name":"Department of Urology, School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Fu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"},{"name":"Department of Urology, School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Khun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"},{"name":"Department of Urology, School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ling","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"},{"name":"Department of Urology, School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Lin","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"},{"name":"Department of Urology, School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"},{"name":"Department of Urology, School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"Suppl 1","key":"R1-20250407","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/318850","article-title":"Urinary tract infections:Disease panorama and challenges","volume":"183","author":"Stamm","year":"2001","journal-title":"J Infect Dis"},{"key":"R2-20250407","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1120009X.2017.1380397","article-title":"Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections","volume":"29","author":"Concia","year":"2017","journal-title":"J Chemother"},{"key":"R3-20250407","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2105\/AJPH.75.11.1308","article-title":"Epidemiology of urinary tract infection:I. Diaphragm use and sexual intercourse","volume":"75","author":"Foxman","year":"1985","journal-title":"Am J Public Health"},{"key":"R4-20250407","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.suc.2016.02.003","article-title":"Diagnosis and management of lower urinary tract dysfunction","volume":"96","author":"McDonough","year":"2016","journal-title":"Surg Clin North Am"},{"key":"R5-20250407","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/luts.12280","article-title":"High incidence of lower urinary tract dysfunction in women with recurrent urinary tract infections","volume":"12","author":"Lee","year":"2020","journal-title":"Low Urin Tract Symptoms"},{"key":"R6-20250407","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jiac.2023.04.019","article-title":"Urinary tract infection in patients with lower urinary tract dysfunction","volume":"29","author":"Kamei","year":"2023","journal-title":"J Infect Chemother"},{"key":"R7-20250407","doi-asserted-by":"crossref","first-page":"7914","DOI":"10.3390\/ijms25147914","article-title":"Profound properties of protein-rich, platelet-rich plasma matrices as novel, multi-purpose biological platforms in tissue repair, regeneration, and wound healing","volume":"25","author":"Everts","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R8-20250407","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.3390\/jcm13154571","article-title":"Systematic review of platelet-rich plasma in medical and surgical specialties: Quality, evaluation, evidence, and enforcement","volume":"13","author":"Rahman","year":"2024","journal-title":"J Clin Med"},{"key":"R9-20250407","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/luts.12364","article-title":"Urothelial health after platelet-rich plasma injection in intractable recurrent urinary tract infection: Improved cell proliferation, cytoskeleton, and barrier function protein expression","volume":"13","author":"Jiang","year":"2021","journal-title":"Low Urin Tract Symptoms"},{"key":"R10-20250407","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/biomedicines10020245","article-title":"Bladder ultrastructure and urinary cytokine abnormality in patients with recurrent urinary tract infection and the changes after intravesical platelet-rich plasma injections","volume":"10","author":"Jhang","year":"2022","journal-title":"Biomedicines"},{"key":"R11-20250407","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/biomedicines10020220","article-title":"Inflammation and barrier function deficits in the bladder urothelium of patients with chronic spinal cord injury and recurrent urinary tract infections","volume":"10","author":"Wu","year":"2022","journal-title":"Biomedicines"},{"key":"R12-20250407","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.3390\/jcm12124129","article-title":"Effectiveness of platelet-rich plasma injections as prophylaxis for recurrent urinary tract infection in women","volume":"12","author":"Lee","year":"2023","journal-title":"J Clin Med"},{"key":"R13-20250407","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.3928\/19382359-20240407-05","article-title":"Review of urinary tract infections and pyelonephritis","volume":"53","author":"Pianucci","year":"2024","journal-title":"Pediatr Ann"},{"key":"R14-20250407","first-page":"45","article-title":"Urinalysis predictive of urine culture results","volume":"40","author":"Bailey","year":"1995","journal-title":"J Fam Pract"},{"key":"R15-20250407","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.0308125100","article-title":"Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis","volume":"101","author":"Justice","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-20250407","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections:Epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"R17-20250407","doi-asserted-by":"crossref","first-page":"e202000948","DOI":"10.26508\/lsa.202000948","article-title":"Urinary prostaglandin E2 as a biomarker for recurrent UTI in postmenopausal women","volume":"4","author":"Ebrahimzadeh","year":"2021","journal-title":"Life Sci Alliance"},{"key":"R18-20250407","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12879-024-09044-2","article-title":"Urine biomarkers individually and as a consensus model show high sensitivity and specificity for detecting UTIs","volume":"24","author":"Akhlaghpour","year":"2024","journal-title":"BMC Infect Dis"},{"key":"R19-20250407","doi-asserted-by":"crossref","first-page":"11772719221144459","DOI":"10.1177\/11772719221144459","article-title":"What is the diagnostic accuracy of novel urine biomarkers for urinary tract infection?","volume":"18","author":"Edwards","year":"2023","journal-title":"Biomark Insights"},{"key":"R20-20250407","first-page":"110","article-title":"Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction","volume":"36","author":"Yu","year":"2024","journal-title":"Tzu Chi Med J"},{"key":"R21-20250407","doi-asserted-by":"crossref","first-page":"931717","DOI":"10.3389\/fmed.2022.931717","article-title":"A systematic review of the (Un) known host immune response biomarkers for predicting recurrence of urinary tract infection","volume":"9","author":"Sori\u0107Hosman","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R22-20250407","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41585-024-00923-6","article-title":"Videourodynamics \u2013Role, benefits and optimal practice","volume":"22","author":"Przydacz","year":"2025","journal-title":"Nat Rev Urol"},{"key":"R23-20250407","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/IJWH.S94956","article-title":"Clinical significance of video-urodynamic in female recurrent urinary tract infections","volume":"8","author":"Hijazi","year":"2016","journal-title":"Int J Womens Health"},{"issue":"(Suppl 6)","key":"R24-20250407","first-page":"S3","article-title":"Bladder outlet obstruction:Etiology and evaluation","volume":"7","author":"Dmochowski","year":"2005","journal-title":"Rev Urol"},{"key":"R25-20250407","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/tcmj.tcmj_178_19","article-title":"Role of videourodynamic study in precision diagnosis and treatment for lower urinary tract dysfunction","volume":"32","author":"Jiang","year":"2020","journal-title":"Tzu Chi Med J"},{"key":"R26-20250407","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/luts.12062","article-title":"Alteration of urothelial inflammation, apoptosis, and junction protein in patients with various bladder conditions and storage bladder symptoms suggest common pathway involved in underlying pathophysiology","volume":"7","author":"Liu","year":"2015","journal-title":"Low Urin Tract Symptoms"},{"key":"R27-20250407","doi-asserted-by":"crossref","first-page":"F732","DOI":"10.1152\/ajprenal.00337.2016","article-title":"Sleeping beauty:Awakening urothelium from its slumber","volume":"312","author":"Balsara","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"R28-20250407","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41385-022-00565-0","article-title":"The urothelium:A multi-faceted barrier against a harsh environment","volume":"15","author":"Jafari","year":"2022","journal-title":"Mucosal Immunol"},{"key":"R29-20250407","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/luts.12351","article-title":"Deficits of urothelial cell proliferation, cytoskeleton, and barrier function protein expressions in patients with recurrent and persistent urinary tract infections","volume":"13","author":"Jhang","year":"2021","journal-title":"Low Urin Tract Symptoms"},{"key":"R30-20250407","doi-asserted-by":"crossref","first-page":"e63760","DOI":"10.1371\/journal.pone.0063760","article-title":"Increased urothelial cell apoptosis and chronic inflammation are associated with recurrent urinary tract infection in women","volume":"8","author":"Chuang","year":"2013","journal-title":"PLoS One"},{"key":"R31-20250407","doi-asserted-by":"crossref","first-page":"484.e7","DOI":"10.1016\/j.urology.2011.09.049","article-title":"Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis\/painful bladder syndrome","volume":"79","author":"Shie","year":"2012","journal-title":"Urology"},{"key":"R32-20250407","doi-asserted-by":"crossref","first-page":"e1006151","DOI":"10.1371\/journal.ppat.1006151","article-title":"Characterization of early-phase neutrophil extracellular traps in urinary tract infections","volume":"13","author":"Yu","year":"2017","journal-title":"PLoS Pathog"},{"key":"R33-20250407","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ni.2109","article-title":"Phenotypic and functional plasticity of cells of innate immunity:Macrophages, mast cells and neutrophils","volume":"12","author":"Galli","year":"2011","journal-title":"Nat Immunol"},{"key":"R34-20250407","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"key":"R35-20250407","doi-asserted-by":"crossref","first-page":"e5990","DOI":"10.1371\/journal.pone.0005990","article-title":"Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women","volume":"4","author":"Hawn","year":"2009","journal-title":"PLoS One"},{"key":"R36-20250407","doi-asserted-by":"crossref","first-page":"e2026461118","DOI":"10.1073\/pnas.2026461118","article-title":"Local induction of bladder Th1 responses to combat urinary tract infections","volume":"118","author":"Wu","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R37-20250407","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41590-020-0688-3","article-title":"Ahighly polarized T (H) 2 bladder response to infection promotes epithelial repair at the expense of preventing new infections","volume":"21","author":"Wu","year":"2020","journal-title":"Nat Immunol"},{"key":"R38-20250407","doi-asserted-by":"crossref","first-page":"eabn4332","DOI":"10.1126\/sciimmunol.abn4332","article-title":"Tissue-resident memory T cells mediate mucosal immunity to recurrent urinary tract infection","volume":"8","author":"Rousseau","year":"2023","journal-title":"Sci Immunol"},{"key":"R39-20250407","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/endrev\/bnac017","article-title":"Estrogen receptor signaling in the immune system","volume":"44","author":"Chakraborty","year":"2023","journal-title":"Endocr Rev"},{"key":"R40-20250407","doi-asserted-by":"crossref","first-page":"190ra80","DOI":"10.1126\/scitranslmed.3005574","article-title":"Estrogen supports urothelial defense mechanisms","volume":"5","author":"L\u00fcthje","year":"2013","journal-title":"Sci Transl Med"},{"key":"R41-20250407","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/UPJ.0000000000000513","article-title":"A cost savings analysis of topical estrogen therapy in urinary tract infection prevention among postmenopausal women","volume":"11","author":"Houston","year":"2024","journal-title":"Urol Pract"},{"key":"R42-20250407","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.euf.2022.05.006","article-title":"Topical and oral oestrogen for recurrent urinary tract infection-evidence-based review of literature, treatment recommendations, and correlation with the European Association of Urology guidelines on urological infections","volume":"8","author":"Antoniou","year":"2022","journal-title":"Eur Urol Focus"},{"key":"R43-20250407","first-page":"367","article-title":"d-mannose for recurrent urinary tract infection prevention in postmenopausal women using vaginal estrogen:A randomized controlled trial","volume":"29","author":"Lenger","year":"2023","journal-title":"Urogynecology (Phila)"},{"key":"R44-20250407","doi-asserted-by":"crossref","first-page":"100753","DOI":"10.1016\/j.xcrm.2022.100753","article-title":"Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiome","volume":"3","author":"Neugent","year":"2022","journal-title":"Cell Rep Med"},{"key":"R45-20250407","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ydbio.2022.11.003","article-title":"Effects of aging on urinary tract epithelial homeostasis and immunity","volume":"493","author":"Ligon","year":"2023","journal-title":"Dev Biol"},{"key":"R46-20250407","doi-asserted-by":"crossref","first-page":"dlad156","DOI":"10.1093\/jacamr\/dlad156","article-title":"Epidemiology and microbiology of recurrent UTI in women in the community in Oxfordshire, UK","volume":"6","author":"Vazquez-Montes","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"R47-20250407","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.55730\/1300-0144.5706","article-title":"Recurrent lower urinary tract infections:More than an infection for older women","volume":"53","author":"Ganida\u011fli","year":"2023","journal-title":"Turk J Med Sci"},{"key":"R48-20250407","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1172\/JCI98595","article-title":"Insulin receptor signaling regulates renal collecting duct and intercalated cell antibacterial defenses","volume":"128","author":"Murtha","year":"2018","journal-title":"J Clin Invest"},{"key":"R49-20250407","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7748\/nop.2022.e1392","article-title":"Diagnosing, managing and preventing urinary tract infections in older people with dementia in hospital","volume":"34","author":"MacRae","year":"2022","journal-title":"Nurs Older People"},{"key":"R50-20250407","doi-asserted-by":"crossref","first-page":"106167","DOI":"10.1016\/j.jinf.2024.106167","article-title":"Population incidence and associated mortality of urinary tract infection in people living with dementia","volume":"88","author":"Lai","year":"2024","journal-title":"J Infect"},{"key":"R51-20250407","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.purol.2018.03.002","article-title":"Original strategy for prevention of recurrent symptomatic urinary tract infections in patients with neurogenic bladder:Bacterial interference, state of the art","volume":"28","author":"Falcou","year":"2018","journal-title":"Prog Urol"},{"key":"R52-20250407","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/nau.25245","article-title":"Risk factors associated with recurrent febrile urinary tract infection in children with neurogenic bladder who perform clean intermittent catheterization","volume":"42","author":"Zhou","year":"2023","journal-title":"Neurourol Urodyn"},{"key":"R53-20250407","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.urology.2021.12.027","article-title":"Risk factors for recurrent urinary tract infection in children with neurogenic bladder following clean intermittent catheterization","volume":"164","author":"Jiang","year":"2022","journal-title":"Urology"},{"key":"R54-20250407","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0970-0218.170962","article-title":"Behavioral and psychosocial risk factors associated with first and recurrent cystitis in Indian women:A case-control study","volume":"41","author":"Mishra","year":"2016","journal-title":"Indian J Community Med"},{"key":"R55-20250407","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s44197-023-00105-4","article-title":"Recurrent urinary tract infection in adult patients, risk factors, and efficacy of low dose prophylactic antibiotics therapy","volume":"13","author":"Alghoraibi","year":"2023","journal-title":"J Epidemiol Glob Health"},{"key":"R56-20250407","doi-asserted-by":"crossref","first-page":"1","DOI":"10.58803\/RBES.2023.2.1.01","article-title":"The power of probiotics to combat urinary tract infections:A comprehensive review","volume":"2","author":"Qasemi","year":"2023","journal-title":"Res Biotechnol Environ Sci"},{"key":"R57-20250407","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/cid\/ciad766","article-title":"Effectiveness of prophylactic oral and\/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections:A randomized, double-blind, placebo-controlled trial","volume":"78","author":"Gupta","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R58-20250407","doi-asserted-by":"crossref","first-page":"377","DOI":"10.5152\/tud.2018.48742","article-title":"The role of probiotics in women with recurrent urinary tract infections","volume":"44","author":"Akg\u00fcl","year":"2018","journal-title":"Turk J Urol"},{"key":"R59-20250407","doi-asserted-by":"crossref","first-page":"636377","DOI":"10.3389\/fphar.2021.636377","article-title":"Considerations on D-mannose mechanism of action and consequent classification of marketed healthcare products","volume":"12","author":"Scaglione","year":"2021","journal-title":"Front Pharmacol"},{"key":"R60-20250407","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.euf.2020.09.004","article-title":"Role of D-mannose in the prevention of recurrent urinary tract infections:Evidence from a systematic review of the literature","volume":"7","author":"Kyriakides","year":"2021","journal-title":"Eur Urol Focus"},{"key":"R61-20250407","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/antibiotics10040373","article-title":"Role of D-mannose in the prevention of recurrent uncomplicated cystitis:State of the art and future perspectives","volume":"10","author":"De Nunzio","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R62-20250407","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamainternmed.2024.0264","article-title":"D-mannose for prevention of recurrent urinary tract infection among women:A randomized clinical trial","volume":"184","author":"Hayward","year":"2024","journal-title":"JAMA Intern Med"},{"key":"R63-20250407","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.euf.2018.07.034","article-title":"Vaccine development for urinary tract infections:Where do we stand?","volume":"5","author":"Magistro","year":"2019","journal-title":"Eur Urol Focus"},{"key":"R64-20250407","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.acuro.2015.04.008","article-title":"Oral vaccine (OM-89) in the recurrent urinary tract infection prophylaxis:A realistic systematic review with meta-analysis","volume":"40","author":"Taha Neto","year":"2016","journal-title":"Actas Urol Esp"},{"key":"R65-20250407","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(17)30108-1","article-title":"Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: A randomised, single-blind, placebo-controlled phase 1b trial","volume":"17","author":"Huttner","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R66-20250407","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1080\/21645515.2020.1834807","article-title":"Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections:Results from a first-in-human phase 1 study","volume":"17","author":"Eldridge","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"R67-20250407","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nchembio.242","article-title":"Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation","volume":"5","author":"Cegelski","year":"2009","journal-title":"Nat Chem Biol"},{"key":"R68-20250407","doi-asserted-by":"crossref","first-page":"e0011224","DOI":"10.1128\/jb.00112-24","article-title":"Identification of a copper-responsive small molecule inhibitor of uropathogenic Escherichia coli","volume":"206","author":"Hanson","year":"2024","journal-title":"J Bacteriol"},{"key":"R69-20250407","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1080\/07391102.2022.2059009","article-title":"Elucidating novel antibacterial compounds from the NPASS database against the FimH lectin domain for the treatment of urinary tract infections:An in-silico study","volume":"41","author":"Al-Zrkani","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"R70-20250407","doi-asserted-by":"crossref","first-page":"107072","DOI":"10.1016\/j.compbiomed.2023.107072","article-title":"Identifying FmlH lectin-binding small molecules for the prevention of Escherichia coli-induced urinary tract infections using hybrid fragment-based design and molecular docking","volume":"163","author":"Samanta","year":"2023","journal-title":"Comput Biol Med"},{"key":"R71-20250407","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4252\/wjsc.v2.i1.1","article-title":"Advances in stem cell therapy for the lower urinary tract","volume":"2","author":"Lin","year":"2010","journal-title":"World J Stem Cells"},{"key":"R72-20250407","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5483\/BMBRep.2022.55.5.035","article-title":"New therapeutic approach with extracellular vesicles from stem cells for interstitial cystitis\/bladder pain syndrome","volume":"55","author":"Dayem","year":"2022","journal-title":"BMB Rep"},{"key":"R73-20250407","doi-asserted-by":"crossref","DOI":"10.1177\/1756287219868590","article-title":"Personal cell therapy for interstitial cystitis with autologous stromal vascular fraction stem cells","volume":"11","author":"Lander","year":"2019","journal-title":"Ther Adv Urol"},{"key":"R74-20250407","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/stcltm\/szac065","article-title":"Safety of human embryonic stem cell-derived mesenchymal stem cells for treating interstitial cystitis:A phase I study","volume":"11","author":"Shin","year":"2022","journal-title":"Stem Cells Transl Med"},{"key":"R75-20250407","first-page":"609","article-title":"The therapeutic effect of intravesical instillation of platelet rich plasma on recurrent bacterial cystitis in women:A randomized clinical trial","volume":"16","author":"Mirzaei","year":"2019","journal-title":"Urol J"},{"key":"R76-20250407","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/ijms25010163","article-title":"The tumor necrosis factor-\u03b1 level in platelet-rich plasma might be associated with treatment outcome in patients with interstitial cystitis\/bladder pain syndrome or recurrent urinary tract infection","volume":"25","author":"Jhang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R77-20250407","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.5213\/inj.2142100.050","article-title":"Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in the patients with interstitial cystitis\/bladder pain syndrome after intravesical platelet-rich plasma injection","volume":"26","author":"Jhang","year":"2022","journal-title":"Int Neurourol J"},{"key":"R78-20250407","doi-asserted-by":"crossref","first-page":"15218","DOI":"10.1038\/s41598-020-72292-0","article-title":"Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci Rep"},{"key":"R79-20250407","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/luts.12504","article-title":"Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis","volume":"15","author":"Kuo","year":"2023","journal-title":"Low Urin Tract Symptoms"},{"key":"R80-20250407","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3390\/biomedicines10051182","article-title":"Changes in the ultrastructure of the bladder urothelium in patients with interstitial cystitis after intravesical injections of platelet-rich plasma","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"R81-20250407","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.5213\/inj.1612720.360","article-title":"Urine proteomics in the era of mass spectrometry","volume":"20","author":"Beasley-Green","year":"2016","journal-title":"Int Neurourol J"},{"key":"R82-20250407","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mas.21455","article-title":"Mass spectrometric based approaches in urine metabolomics and biomarker discovery","volume":"36","author":"Khamis","year":"2017","journal-title":"Mass Spectrom Rev"},{"key":"R83-20250407","doi-asserted-by":"crossref","first-page":"e13856","DOI":"10.1111\/aji.13856","article-title":"Identification of urine biomarkers of endometriosis-protein mass spectrometry","volume":"91","author":"Vi\u0161ni\u0107","year":"2024","journal-title":"Am J Reprod Immunol"},{"key":"R84-20250407","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/cancers15041166","article-title":"Mass spectrometry-based biomarkers to detect prostate cancer:A multicentric study based on non-invasive urine collection without prior digital rectal examination","volume":"15","author":"Frantzi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R85-20250407","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1074\/mcp.R600004-MCP200","article-title":"Discovery of urinary biomarkers","volume":"5","author":"Pisitkun","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"R86-20250407","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5584\/jiomics.v4i2.177","article-title":"Quantitative mass spectrometry of urinary biomarkers","volume":"4","author":"Jerebtsova","year":"2014","journal-title":"J Integr OMICS"},{"key":"R87-20250407","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12920-015-0109-x","article-title":"Biomarker discovery:Quantification of microRNAs and other small non-coding RNAs using next generation sequencing","volume":"8","author":"Lopez","year":"2015","journal-title":"BMC Med Genomics"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_286_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:56:45Z","timestamp":1786647405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_286_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_286_24","relation":{},"ISSN":["1016-3190","2223-8956"],"issn-type":[{"value":"1016-3190","type":"print"},{"value":"2223-8956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-11-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}